NUVL

Nuvalent, Inc.

87.27 USD
+0.01 (+0.01%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Nuvalent, Inc. stock is up 14.38% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 6 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 8 PUTs, 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Feb 18:39 19 Jul, 2024 50.00 PUT 134 1924
05 Feb 20:00 19 Jul, 2024 50.00 PUT 272 1924
07 Feb 14:49 19 Jul, 2024 50.00 PUT 148 2424
08 Feb 16:36 19 Jul, 2024 50.00 PUT 250 2579
08 Feb 20:55 19 Jul, 2024 50.00 PUT 204 2579
09 Feb 15:28 19 Jul, 2024 50.00 PUT 325 3033
14 Feb 19:25 19 Jul, 2024 50.00 PUT 425 3708
15 Feb 15:10 15 Mar, 2024 85.00 CALL 50 71
15 Feb 19:50 15 Mar, 2024 85.00 CALL 50 71
16 Feb 16:12 19 Jul, 2024 50.00 PUT 350 4145

About Nuvalent, Inc.

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations.